UnitedHealth Stock Receives Price Target Boost Ahead of Q3 Earnings
Morgan Stanley has raised its price target on UnitedHealth (UNH) ahead of the company's third-quarter earnings release on October 28, 2025. The stock, which has struggled throughout 2025 due to weak results, leadership transitions, and regulatory scrutiny, saw a recent surge after management projected improved Medicare Advantage plan ratings for 2026.
Analyst Erin Wright, ranked in the top 3% of Wall Street experts, described the update as incrementally positive, noting stronger-than-expected member retention rates. UnitedHealth's strategic shift toward value-based care, with near-term adjustments for sustainability, suggests potential for operational improvement.